43200EGP
- Active ingredient
- pertuzumab
- Strength
- 420mg/14ml
- Form
- vial
- Manufacturer
- f.hoffman la roche
- Route
- injection
Uses
Treatment of HER2-positive breast cancer in combination with other anticancer therapies.
Do not use if
Hypersensitivity to pertuzumab or formulation components.
Side effects
Diarrhea, fatigue, infusion reactions, and decreased cardiac function.
Warnings
Cardiac function monitoring is recommended during treatment.
How it works
Monoclonal antibody that inhibits HER2 receptor signaling.
Storage
Store refrigerated at 2–8°C. Do not freeze.